UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 7, 2006
Lifeline Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
| | | | | |
| Colorado | | 000-30489 | | 90-0224471 |
| | | | | |
(State or other jurisdiction
of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | | |
| 6400 South Fiddler’s Green Circle, Suite 1970, Greenwood Village, | | CO 80111 |
| |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code:(720) 488-1711
6400 South Fiddler’s Green Circle, Suite 1750, Englewood, CO 80111
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 7.01Regulation FD Disclosure
Beginning September 7, 2006 and thereafter, management of the company intends to hold discussions and/or meetings with shareholders. The attached presentation, dated September 2006, includes the information to be discussed. The presentation is attached as Exhibit 99.1 hereto.
ITEM 9.01.Exhibits
99.1 Presentation dated “September 2006”
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: September 7, 2006
| | | | | |
| | LIFELINE THERAPEUTICS, INC.
| |
| | By: | /s/ Stephen K. Onody | |
| | | Stephen K. Onody | |
| | | Chief Executive Officer | |
3
EXHIBIT INDEX
| | | |
| Exhibit No. | | Description |
| |
| 99.1 | | Presentation dated “September 2006” |
